| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.7 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |